Communication following the announcement of FDA Breakthrough Device Designation for the Prima System in Dry AMD
03.04.2023 - Communication following the announcement of FDA Breakthrough Device Designation for the Prima System in Dry AMD Conversion of 160 ORNAN2022 by ESGO with intention to pursue controlled trading of sharesCost reduction measures implemented ... Seite 1
Source: wallstreet-online.de